Showing posts with label Cefodizime. Show all posts
Showing posts with label Cefodizime. Show all posts

Monday, October 21, 2013

Dosage and Administration of Cefodizime


Cefodizime can be administered intramuscularly, or by intravenous bolus or infusion. The a lot of frequently acclimated developed dosage in analytic trials has been 2 or 4g circadian in 1 or 2 disconnected doses, either intramuscularly or intravenously. For apprehensible lower urinary amplitude infections individual doses of 1 or 2g accept been effective. In patients with gonorrhoea 0.25 to 1g as a individual dosage has resulted in analytic and bacteriological cure ante of around 100%. Dosage should be adapted in patients with renal impairment, with a best of cefodizime 2g circadian accustomed to patients with a creatinine approval of 0.6 to 1.8 L/h (10 to 30 ml/min), and bisected this dosage to patients with a creatinine approval of < 0.6 L/h (< 10 ml/min). In patients ability haemodialysis, cefodizime 1 to 2g should be administered afterwards anniversary dialysis cycle. A dosage of 60 mg/kg/day (typically in 3 to 4 disconnected doses) is frequently acclimated for the analysis of infections in paediatric populations, except in bacterial meningitis area 200 mg/kg/day (in 4 disconnected doses) has been administered.

more about:
pharmaceutical chemicals online